BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27019331)

  • 1. Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.
    Wen S; Li Z; Feng J; Bai J; Lin X; Huang H
    Cancer Sci; 2016 Jun; 107(6):836-45. PubMed ID: 27019331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.
    Lin X; Zhan B; Wen S; Li Z; Huang H; Feng J
    Mol Biosyst; 2016 Aug; 12(9):2883-92. PubMed ID: 27400832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.
    Wen S; Zhan B; Feng J; Hu W; Lin X; Bai J; Huang H
    BMC Cancer; 2017 Nov; 17(1):708. PubMed ID: 29096620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
    Iakovlev V; Siegel ER; Tsao MS; Haun RS
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.
    Ligat L; Saint-Laurent N; El-Mrani A; Gigoux V; Al Saati T; Tomasini R; Nigri J; Dejean S; Pont F; Baer R; Guillermet-Guibert J; Cordelier P; Lopez F; Dufresne M
    Br J Cancer; 2015 Dec; 113(11):1590-8. PubMed ID: 26512875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues.
    Wang S; Wen S; Guo P; Liu H; Feng J; Huang H
    J Pharm Biomed Anal; 2020 Oct; 190():113546. PubMed ID: 32846403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules.
    Hu J; Jiang J; Xu B; Li Y; Wang B; He S; Ren X; Shi B; Zhang X; Zheng H; Hua B; Liu R
    J Ethnopharmacol; 2024 Mar; 322():117590. PubMed ID: 38113986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
    Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
    Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models.
    Wang L; Liu HL; Li Y; Yuan P
    World J Gastroenterol; 2011 Mar; 17(11):1434-41. PubMed ID: 21472101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
    Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
    Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mAb Das-1 identifies pancreatic ductal adenocarcinoma and high-grade pancreatic intraepithelial neoplasia with high accuracy.
    Das KK; Brown JW; Fernandez Del-Castillo C; Huynh T; Mills JC; Matsuda Y; Das KM; Mino-Kenudson M
    Hum Pathol; 2021 May; 111():36-44. PubMed ID: 33524436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC).
    Zińczuk J; Zaręba K; Romaniuk W; Kamińska D; Nizioł M; Baszun M; Kędra B; Guzińska-Ustymowicz K; Pryczynicz A
    Int J Med Sci; 2019; 16(4):583-592. PubMed ID: 31171910
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early requirement of Rac1 in a mouse model of pancreatic cancer.
    Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
    Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
    Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
    APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.